MFDS
- Status: likely_approved
🇰🇷 Prolixin Decanoate in South Korea
Prolixin Decanoate (FLUPHENAZINE DECANOATE) regulatory status in South Korea.
Marketing authorisation
Prolixin Decanoate in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in South Korea
Frequently asked questions
Is Prolixin Decanoate approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Prolixin Decanoate in South Korea?
Bristol-Myers Squibb is the originator. The local marketing authorisation holder may differ — check the official source linked above.